AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Adhesive CapsulitisFrozen Shoulder
Interventions
BIOLOGICAL

AA4500 0.29 mg/1 mL

treatment of adhesive capsulitis

BIOLOGICAL

AA4500 0.58 mg/2 mL

treatment of adhesive capsulitis

BIOLOGICAL

AA4500 0.58 mg/1 mL

treatment of adhesive capsulitis

BIOLOGICAL

AA4500 0.58 mg/0.5 mL

treatment of adhesive capsulitis

OTHER

Shoulder exercises

Home shoulder exercises, minimum of 3 times per day

Trial Locations (15)

11794

Stony Brook University Medical Center, Stony Brook

16602

Blair Orthopedic Associates, Inc., Altoona

33781

Advent Clinical Research, Pinellas Park

35209

Alabama Orthopaedic Center - Research, Birmingham

37043

Alpha Clinical Research, LLC, Clarksville

44143

David R. Mandel, MD, Inc., Cleveland

46260

The Indiana Hand to Shoulder Center, Indianapolis

61107

Rockford Orthopedic Associates, Rockford

72205

OrthoArkansas, Little Rock

73109

Health Research Institute, Oklahoma City

79761

Basin Orthopedic Surgical Specialists, Odessa

85050

HOPE Research Institute, Phoenix

85712

Tucson Orthopaedic Institute, Tucson

91942

Triwest Research Associates, La Mesa

92024

CORE Orthopaedic Medical Center, Encinitas

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY